Concepedia

Prostaglandin E2 Inhibition and Aqueous Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients Undergoing Phacoemulsification

Frank A. Bucci, L. David Waterbury, L.M. Amico

American Journal of Ophthalmology · 2007 · 39 citations · 1 references

DOI

Concepts

References

1

The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.

Maria G. Sciulli, Marta L. Capone, Stefania Tacconelli et al. · PubMed · 2005 · 30 citations